Region:Asia
Author(s):Geetanshi
Product Code:KRAA4147
Pages:96
Published On:January 2026
By Method:The market is segmented into three primary methods of gene synthesis: solid-phase synthesis, chip-based synthesis, and PCR-based enzyme synthesis. PCR-based enzyme synthesis currently accounts for the largest revenue share in Thailand due to its suitability for high-throughput workflows, longer constructs, and applications in synthetic biology and gene editing research. Solid-phase synthesis remains widely used for shorter constructs and routine DNA fragments, while chip-based synthesis is gaining traction for its ability to generate large numbers of sequences in parallel for screening and library applications.
By Service Type:The service type segmentation includes custom gene synthesis, gene library synthesis, oligonucleotide synthesis for research, and gene fragments & partial constructs. Custom gene synthesis leads demand as research groups and biotechnology companies increasingly require tailored constructs for applications in gene editing, vaccine development, and functional genomics. Gene library synthesis is crucial for high-throughput screening in drug discovery and synthetic biology, while oligonucleotide synthesis is widely used across PCR, qPCR, sequencing, and diagnostic assay development. Gene fragments and partial constructs are essential building blocks for modular cloning strategies and rapid assembly of larger synthetic genes.
The Thailand Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as Thermo Fisher Scientific Inc., Integrated DNA Technologies (IDT), GenScript Biotech Corporation, Eurofins Genomics, Twist Bioscience Corporation, Synthetic Genomics Inc. (SGI-DNA / Codex DNA), Biomatik Corporation, Bioneer Corporation, ATUM, Inc., LGC Biosearch Technologies, GeneArt (Thermo Fisher Scientific), ProteoGenix, Brooks Automation / Azenta Life Sciences, Origene Technologies Inc., and other emerging regional players in Southeast Asia contribute to innovation, geographic expansion, and service delivery in this space.
The future of the Thailand gene synthesis market appears promising, driven by technological advancements and increased funding. As the government continues to prioritize biotechnology, the sector is likely to see enhanced collaboration between research institutions and private companies. Furthermore, the integration of artificial intelligence in genetic research is expected to streamline processes and improve outcomes. These trends will foster a more dynamic environment, encouraging innovation and expanding the applications of gene synthesis in various fields, including healthcare and agriculture.
| Segment | Sub-Segments |
|---|---|
| By Method | Solid-phase synthesis Chip-based synthesis PCR-based enzyme synthesis |
| By Service Type | Custom gene synthesis Gene library synthesis Oligonucleotide synthesis for research Gene fragments & partial constructs |
| By Application | Synthetic biology & pathway engineering Drug discovery & development Molecular diagnostics & assay development Functional genomics & gene expression studies Other research applications |
| By End-User | Academic & government research institutes Biotech companies Pharmaceutical companies Contract research organizations (CROs) |
| By DNA Construct Length | ?1 kb –5 kb –10 kb >10 kb |
| By Delivery Format | Cloned into standard plasmid vectors Linear gene fragments Customized vector constructs |
| By Customer Type | Domestic Thailand-based customers International customers sourcing from Thailand |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Pharmaceutical Applications | 120 | R&D Directors, Product Development Managers |
| Agricultural Biotechnology | 90 | Biotech Researchers, Agronomists |
| Academic Research Institutions | 80 | University Professors, Lab Managers |
| Contract Research Organizations (CROs) | 70 | Business Development Managers, Project Leads |
| Startups in Gene Therapy | 60 | Founders, Chief Scientific Officers |
The Thailand Gene Synthesis Research Use Market is valued at approximately USD 25 million, reflecting a five-year historical analysis. This growth is attributed to advancements in biotechnology, genomics, and increased focus on precision medicine.
What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
